Evidence map›Paper›PMID 41708752›Full record

ArticleScientific reports2026

GluN2A-mediated currents and calcium signal in human iPSC-derived neurons.

Sergio Escamilla, Carlos Avilés-Granados, Francisco Andrés Peralta, Ana V Paternain, María-Ángeles Cortés-Gómez, Henrik Zetterberg, Elvira de la Peña, Federico Salas-Lucia, Javier Sáez-Valero, Inmaculada Cuchillo-Ibáñez

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sergio EscamillaInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
Carlos Avilés-GranadosInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
Francisco Andrés PeraltaInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
Ana V PaternainInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
María-Ángeles Cortés-GómezInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Elvira de la PeñaInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
Federico Salas-LuciaSection of Adult and Pediatric Endocrinology, Diabetes and Metabolism, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Javier Sáez-ValeroInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain.
Inmaculada Cuchillo-IbáñezInstituto de Neurociencias, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas (UMH-CSIC), 03550, Sant Joan d' Alacant, Alicante, Spain. icuchillo@umh.es.ORCID http://orcid.org/0000-0002-3689-5518

Funding

Agencia Estatal de Investigación (AEI) and the Ministerio de Ciencia e Innovación (MCIN) under the Plan Estatal de I+D+I 2021-2023, co-funded by the European Social Fund (FSE) PRE2022-104182Conselleria de Educación, Cultura, Universidades y Empleo CIPROM/2022/08Direcció General de Ciència i Investigació, Generalitat Valenciana CIAICO/2024/313European Union's Horizon Europe 101053962Fondo de Investigaciones Sanitarias PI22/01329Fondo de Investigaciones Sanitarias co-funded by the Fondo Europeo de Desarrollo Regional, FEDER "Investing in your future"), PI22/01329Generalitat Valenciana PROMETEO/2019/014Generalitat Valenciana Government PROMETEO/2021/031MCIN/AEI/10.13039/501100011033 PID2022-140961OB-100Severo Ochoa" Program for Centers of Excellence in R&D CEX2021-001165-SSpanish Agency of Research (AEI) PID2022-136741NB-100Swedish Research Council #2023-00356, #2022-01018 and #2019-02397Swedish State Support for Clinical Research ALFGBG-71320
6 · The paper itself

Abstract

Gene expression data indicate that during human brain development, neurons change the NMDA receptor (NMDAR) subunit composition to modulate their function, favouring the GluN2A subunit over GluN2B-a hallmark of neuronal maturation. However, evidence supporting this phenomenon in human iPSC-derived neurons remains elusive. Here, using two differentiation methods in parallel (BrainPhys Neuronal Medium, BPM, and Neural Maintenance Medium, NMM), we provide evidence of increased synaptic localization of NMDARs during neuronal maturation and that GluN2A subunit is crucial for the NMDA physiological function-inducing inward currents and calcium entrance at 60 days of differentiation. Calcium responses to specific agonists, particularly NMDA, were elevated in cells cultured under BPM conditions. This is likely attributable to their more mature neuronal phenotype and the RNA-seq identified upregulation of genes involved in intracellular calcium signaling proteins. Our results offer insight into how glutamate receptor subunits mature during brain development, delineating approaches to study NMDAR activity in health and disease.

Indexed as

Calcium SignalingInduced Pluripotent Stem CellsNeuronsReceptors, N-Methyl-D-AspartateCalciumCell DifferentiationCells, CulturedHumansCalciumReceptors, N-Methyl-D-AspartateCerebral cortex developmentGluN2BNeurodifferentiationNMDARRo 25–6981

Identifiers

PMID41708752
PMCPMC13013697

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.